Disposition of 56250 shares by Walter Klemp of Moleculin Biotech subject to Rule 16b-3

AMIX Stock   3.15  0.20  5.97%   
Slightly above 63% of Autonomix Medical,'s investor base is looking to short. The analysis of overall sentiment of trading Autonomix Medical, Common stock suggests that many investors are alarmed at this time. Autonomix Medical,'s investing sentiment can be driven by a variety of factors including economic data, Autonomix Medical,'s earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Moleculin Biotech Director, Officer Ceo And President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Moleculin insider trading alert for disposition of restricted stock units by Walter Klemp, Director, Officer: Ceo And President, on 12th of December 2024. This event was filed by Moleculin Biotech with SEC on 2023-06-20. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Autonomix Medical,'s cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Autonomix Medical,'s relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Autonomix Medical, Fundamental Analysis

We analyze Autonomix Medical,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Autonomix Medical, is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Autonomix Medical, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Autonomix Medical, stock to make a market-neutral strategy. Peer analysis of Autonomix Medical, could also be used in its relative valuation, which is a method of valuing Autonomix Medical, by comparing valuation metrics with similar companies.

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.